Lazard Asset Management’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $677K | Buy |
54,486
+86
| +0.2% | +$1.16K | ﹤0.01% | 1289 |
|
|
2025
Q4 | $685K | Buy |
54,400
+5
| +0% | +$57 | ﹤0.01% | 1264 |
|
|
2025
Q3 | $544K | Sell |
54,395
-2,038
| -4% | -$18.3K | ﹤0.01% | 1331 |
|
|
2025
Q2 | $455K | Buy |
56,433
+5,643
| +11% | +$42.5K | ﹤0.01% | 1511 |
|
|
2025
Q1 | $424K | Buy |
50,790
+8,727
| +21% | +$72.8K | ﹤0.01% | 1447 |
|
|
2024
Q4 | $332K | Buy |
42,063
+11,764
| +39% | +$98.7K | ﹤0.01% | 1478 |
|
|
2024
Q3 | $251K | Sell |
30,299
-47,829
| -61% | -$374K | ﹤0.01% | 1554 |
|
|
2024
Q2 | $495K | Buy |
78,128
+77,167
| +8,030% | +$490K | ﹤0.01% | 1203 |
|
|
2024
Q1 | $5K | Buy |
961
+2
| +0.2% | +$11 | ﹤0.01% | 1897 |
|
|
2023
Q4 | $5K | Buy |
+959
| New | +$4.27K | ﹤0.01% | 2120 |
|
|
2023
Q2 | – | Sell |
-4,079
| Closed | -$5K | – | 2285 |
|
|
2023
Q1 | $5K | Sell |
4,079
-12,834
| -76% | -$25.6K | ﹤0.01% | 2160 |
|
|
2022
Q4 | $33K | Hold |
16,913
| – | – | ﹤0.01% | 1977 |
|
|
2022
Q3 | $34K | Buy |
16,913
+4,079
| +32% | +$11.4K | ﹤0.01% | 1938 |
|
|
2022
Q2 | $40K | Hold |
12,834
| – | – | ﹤0.01% | 1905 |
|
|
2022
Q1 | $53K | Hold |
12,834
| – | – | ﹤0.01% | 1707 |
|
|
2021
Q4 | $61K | Buy |
12,834
+2,494
| +24% | +$12.4K | ﹤0.01% | 1644 |
|
|
2021
Q3 | $55K | Buy |
+10,340
| New | +$52.1K | ﹤0.01% | 1636 |
|
|
2021
Q2 | – | Sell |
-4,206
| Closed | -$28K | – | 1949 |
|
|
2021
Q1 | $28K | Sell |
4,206
-3,084
| -42% | -$17.1K | ﹤0.01% | 1665 |
|
|
2020
Q4 | $33K | Buy |
+7,290
| New | +$32.3K | ﹤0.01% | 1525 |
|
|
2020
Q3 | – | Sell |
-11,839
| Closed | -$56K | – | 1601 |
|
|
2020
Q2 | $56K | Buy |
+11,839
| New | +$48.8K | ﹤0.01% | 1199 |
|
Other funds holding AMRX
TGA
VPM
RCMNY
VCM
